Document is current
Any future updates will be listed below
-
Authors
Leite, Kátia Ramos Moreira https://orcid.org/0000-0002-2615-7730
Barrios, Carlos Henrique
Buzaid, Antônio Carlos
Gagliato, Débora
Gobbi, Helenice
Soares, Fernando
- License Information
-
More Information
Article History
Received: 16 January 2021
Accepted: 31 March 2021
First Online: 20 April 2021
Declarations
:
: Not applicable.
: The authors consented to the publication.
: <b>Antônio Carlos Buzaid, MD</b>Advisor Roche, MSD, BMS, Lilly, Pfizer, Blau, AstraZeneca<b>Carlos H. Barrios, MD</b>Grants/research support: (to the institution) Pfizer, Novartis, Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Roche/Genentech, Lilly, Sanofi, Taiho Pharmaceutical, Mylan, Merrimack, Merck, AbbVie, Astellas Pharma, BioMarin, Bristol-Myers Squibb, Daiichi Sankyo, Abraxis Biosciences, AB Science, Asana Biosciences, Medivation, Exelixis, ImClone Systems, LEO Pharma, MillenniumAdvisory Boards and Consulting: Boehringer-Ingelheim, GSK, Novartis, Pfizer, Roche/Genentech, Eisai, Bayer, MSD, Astra Zeneca, Lilly.<b>Débora de Melo Gagliato, MD</b>Speaker fees: Roche, AstraZeneca, Pfizer, Lilly, Amgen, United Medical, and Libbs.Consulting: Libbs.The other authors declare that they have no competing interests.
